.
Press Releases
|
Mar 02, 2023 |
|
Biostage Announces Chairman and CEO Transition
|
|
Jan 12, 2023 |
|
Biostage Amends CEO Employment Agreement
|
|
Dec 28, 2022 |
|
Biostage Selects IQVIA to Manage its FDA-Approved Clinical Trial in Severe Esophageal Disease, including Cancer
|
|
Dec 23, 2022 |
|
New Publication Demonstrates Rapid Esophageal Regeneration using the Biostage Esophageal Implant
|
|
Oct 25, 2022 |
|
Biostage Receives U.S. Patent for Cellularized Patch-Based Scaffolds for Organ Repair
|
|
Aug 08, 2022 |
|
Biostage Announces Appointment of New Chief Financial Officer
|
|
Aug 04, 2022 |
|
Biostage Reports Corporate Highlights and Second Quarter Financial Results
|
|
Aug 04, 2022 |
|
Biostage Schedules Conference Call and Webcast for Q2 2022 Results
|
|
Jun 15, 2022 |
|
Biostage Announces Publication of Mechanical Strength Data for Regenerated Esophageal Tissue in Journal of Biomechanics
|
|
May 16, 2022 |
|
Biostage Reports Q1 2022 Financial Results and Corporate Highlights
|